Novartis Inc.'s share price has increased by 0.57% in the current market session. However, the stock has decreased by 0.74% over the past month, but it has spiked by 26.68% in the past year. The company's P/E ratio is lower than the aggregate P/E of the Pharmaceuticals industry, which could indicate that the stock is undervalued. However, a lower P/E can also suggest that shareholders do not expect future growth. Therefore, the short term impact on the stock price is neutral.